Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
, 33 (1), 1-2

Neurotrophins and Neuropathic Pain in Patients With Traumatic Brain Injury

Affiliations
Editorial

Neurotrophins and Neuropathic Pain in Patients With Traumatic Brain Injury

Jiseok Baik. Korean J Pain.

Conflict of interest statement

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

Similar articles

See all similar articles

References

    1. Wurzelmann M, Romeika J, Sun D. Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury. Neural Regen Res. 2017;12:7–12. doi: 10.4103/1673-5374.198964. - DOI - PMC - PubMed
    1. Khan N, Smith MT. Neurotrophins and neuropathic pain: role in pathobiology. Molecules. 2015;20:10657–88. doi: 10.3390/molecules200610657. - DOI - PMC - PubMed
    1. Kowiański P, Lietzau G, Czuba E, Waśkow M, Steliga A, Moryś J. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol. 2018;38:579–93. doi: 10.1007/s10571-017-0510-4. - DOI - PMC - PubMed
    1. Marcol W, Kotulska K, Larysz-Brysz M, Kowalik JL. BDNF contributes to animal model neuropathic pain after peripheral nerve transection. Neurosurg Rev. 2007;30:235–43. doi: 10.1007/s10143-007-0085-5. - DOI - PubMed
    1. Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Grãos MM, et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 2005;12:1329–43. doi: 10.1038/sj.cdd.4401662. - DOI - PubMed

Publication types

LinkOut - more resources

Feedback